CD8A and acute myeloid leukemia: According to Wang’s research, MDSCs were shown to be increased in the peripheral blood of AML patients, and VISTA knockdown significantly decreased the ability of these cells to inhibit PD-1-expressing CD8+ T cells in AML [93].